Keyphrases
Immune Function
100%
Leishmania
100%
Amphotericin B
100%
Arabinogalactan
73%
Tumor Necrosis Factor-α
46%
Fungizone
33%
Inhibitory Effect
13%
B Cells
6%
B Lymphocytes
6%
Water-soluble
6%
Interferon-α (IFN-α)
6%
β-cell Proliferation
6%
Immune Regulation
6%
Nitric Oxide
6%
Cholesterol
6%
Lipopolysaccharide
6%
Human Monocytes
6%
Therapeutic Efficacy
6%
Concanavalin A (Con A)
6%
Phagocytic Cells
6%
Non-conjugated
6%
Surface Membrane
6%
Lymphocyte Stimulation
6%
Cell-mediated Immune Response
6%
Peritoneal Macrophages
6%
T Cell Proliferation
6%
Preferential Binding
6%
Nitric Oxide Release
6%
Sterols
6%
Ergosterol
6%
Polysaccharide Conjugates
6%
Antileishmanial Activity
6%
T Lymphocyte Response
6%
Axenic Amastigotes
6%
Commercial Preparations
6%
Pharmacology, Toxicology and Pharmaceutical Science
Leishmania
100%
Amphotericin B Derivative
100%
Amphotericin B
100%
Arabinogalactan
78%
Tumor Necrosis Factor
50%
Amphotericin B Deoxycholate
35%
Nitric Oxide
14%
Mouse
7%
Ergosterol
7%
Lipopolysaccharide
7%
Polysaccharide
7%
Sterol
7%
Combination Therapy
7%
Interferon
7%
Concanavalin A
7%
Amastigote
7%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Leishmania
100%
B Cell
42%
Interferon Type I
14%
Monocyte
14%
Adoptive Immunity
14%
Macrophage
14%
T Cell Proliferation
14%
Phagocyte
14%
Axenic
14%
Surface Property
14%
Mouse
14%
Lymphocyte Activation
14%
Conjugate
14%
T Cell
14%
Concanavalin A
14%
Amastigote
14%